PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.

Saved in:
Bibliographic Details
Title: PET imaging to non-invasively study immune activation leading to antitumor responses with a 4-1BB agonistic antibody.
Authors: Escuin-Ordinas H; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA., Elliott MW; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA., Atefi M; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA., Lee M; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA., Ng C; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA., Wei L; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA., Comin-Anduix B; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA., Montecino-Rodriguez E; Department of Pathology and Laboratory Medicine, UCLA, Los Angeles, USA., Avramis E; Department of Surgery (Division of Surgical-Oncology), UCLA, Los Angeles, USA., Radu C; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA., Sharp LL; Pfizer Worldwide Research and Development, Oncology Research Unit, San Diego, CA, USA ; Current address: Genomics Institute of the Novartis Research Foundation, 10675 John Jay Hopkins Dr., San Diego, CA 92121, USA., Ribas A; Department of Medicine (Division of Hematology-Oncology) at David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, USA ; Ahmanson Translational Imaging Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, USA ; Jonsson Comprehensive Cancer Center (JCCC), Los Angeles, USA ; Department of Medicine, Division of Hematology-Oncology, 11-934 Factor Building, Jonsson Comprehensive Cancer Center at UCLA, 10833 Le Conte Avenue, Los Angeles, CA 90095-1782, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2013 Aug 27; Vol. 1, pp. 14. Date of Electronic Publication: 2013 Aug 27 (Print Publication: 2013).
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: eCollection Cited Medium: Print ISSN: 2051-1426 (Print) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2051-1426
DOI:10.1186/2051-1426-1-14